{"nct_id":"NCT05449444","title":"Masitinib for the Treatment of Severe Mast Cell Activation Syndrome","status":"UNKNOWN","status_verified_date":"2023-02","start_date":"2022-07-01","start_date_type":"ACTUAL","primary_completion_date":"2024-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2024-12-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["TXMD"]}